Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
News
Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
US study reveals interferon combinations cause lupus symptoms and affect treatment
The autoimmune disease, which affects 1.5 million people in the US, causes the body’s immune system to attack its own tissues
NIHR and TJBCM announce new funding initiative for novel brain tumour research
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
More than 3,000 people in England were affected by Strep A between September 2022 and May 2023
Study reveals heart failure device could monitor patients and prevent hospitalisation
Heart failure is a cardiovascular disease that affects more than 64 million people worldwide
MIT’s new MRI brain light-detecting technique could support brain cell studies
Bioluminescence used MRI to observe the dilation of luciferase in engineered blood vessels
PharmaTimes MSEA and NIEA awards are open for entry
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024
BBSRC invests £48m in Babraham Institute to advance lifelong health research
The funding will help to support research across epigenetics, immunology and cell signalling
NHS reduces long waits for cancer care and achieves faster ambulance responses
For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer
MHRA’s AI Airlock to address challenges for regulating AI medical devices
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
Oregon and Lantern collaborate to develop drug candidate for various cancer indications
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
OneChain’s CAR T trial treats its first cortical T-cell ALL patient
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
The findings could potentially lead to new therapies and could stop the growth of cancers
